UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized controlled trial of the Valencia model of waking hypnosis plus CBT for pain, fatigue, and sleep management in patients with cancer and cancer survivors

Psycho-oncology (Chichester, England), 2017-11, Vol.26 (11), p.1832-1838

2017

Volltextzugriff (PDF)

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

Annals of oncology, 2008-03, Vol.19 (3), p.420-432

2008

Volltextzugriff (PDF)

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer

Breast cancer research and treatment, 2016-08, Vol.158 (3), p.485-495

2016

Volltextzugriff (PDF)

Abstract ES5-3: Late recurrence in ER-positive breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.ES5-3-ES5-3

Gralow, J

2019

Volltextzugriff (PDF)

Optimising the dose of capecitabine in metastatic breast cancer: confused, clarified or confirmed?

Annals of oncology, 2010-11, Vol.21 (11), p.2145-2152

2010

Volltextzugriff (PDF)

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100

British journal of cancer, 2014-09, Vol.111 (6), p.1241-1248

2014

Volltextzugriff (PDF)

Promoting quality and evidence-based care in early-stage breast cancer follow-up

JNCI : Journal of the National Cancer Institute, 2014-04, Vol.106 (4), p.dju034-dju034

2014

Volltextzugriff (PDF)

Characterisation of the HLA-DRB107:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes

The pharmacogenomics journal, 2018-05, Vol.18 (3), p.480-486

2018

Volltextzugriff (PDF)

EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial

British journal of cancer, 2014-09, Vol.111 (6), p.1065-1071

2014

Volltextzugriff (PDF)

High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer

Journal of clinical oncology, 1997-11, Vol.15 (11), p.3363-3367

1997

Volltextzugriff (PDF)

Granulocyte-macrophage colony-stimulating factor : An effective adjuvant for protein and peptide-based vaccines

Blood, 1996-07, Vol.88 (1), p.202-210

1996

Volltextzugriff (PDF)

Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer

The pharmacogenomics journal, 2014-06, Vol.14 (3), p.241-247

2014

Volltextzugriff (PDF)

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

The New England journal of medicine, 2016-07, Vol.375 (3), p.209-219

2016

Volltextzugriff (PDF)

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

The New England journal of medicine, 2017-09, Vol.377 (12), p.1119-1131

2017

Volltextzugriff (PDF)

Summary of the National Cancer Institute (NCI) State of the Science Conference on preoperative therapy in invasive breast cancer

European journal of cancer supplements, 2008, Vol.6 (7), p.107-107

Gralow, J

2008

Volltextzugriff (PDF)

Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer

Journal of clinical oncology, 1997-04, Vol.15 (4), p.1395-1400

1997

Volltextzugriff (PDF)

Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]‐sestamibi scintimammography

Cancer, 1999-06, Vol.85 (11), p.2410-2423

1999

Volltextzugriff (PDF)

Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations

Journal of clinical oncology, 2010-04, Vol.28 (12), p.2114-2122

2010

Volltextzugriff (PDF)

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

The Lancet (British edition), 2015-10, Vol.386 (10001), p.1353-1361

2015

Volltextzugriff (PDF)

PCN153 A Trial for Evaluating Breast Cancer Tumor Marker Use Impact: A Value of Research Analysis

Value in health, 2012-06, Vol.15 (4), p.A235-A235

2012

Volltextzugriff (PDF)

[18F]Fluoroestradiol Radiation Dosimetry in Human PET Studies

The Journal of nuclear medicine (1978), 2001-04, Vol.42 (4), p.679-684

2001

Volltextzugriff (PDF)

Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood

Cancer research (Chicago, Ill.), 1995-03, Vol.55 (5), p.1099-1104

1995

Volltextzugriff (PDF)

Managing Metastatic Bone Pain: The Role of Bisphosphonates

Journal of pain and symptom management, 2007-04, Vol.33 (4), p.462-472

2007

Volltextzugriff (PDF)

American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004

Journal of clinical oncology, 2005-01, Vol.23 (3), p.619-629

2005

Volltextzugriff (PDF)

5025 POSTER DISCUSSION Phase 3 Study of Iniparib (I) Plus Gemcitabine (G) and Carboplatin (C) in Metastatic Triple-negative Breast Cancer (mTNBC) – Results of an Exploratory Analysis by Prior Therapy

European journal of cancer (1990), 2011, Vol.47, p.S338-S338

2011

Volltextzugriff (PDF)

1 – 25 von 281

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(274)
Mit Volltextzugriff
(253)

Publikationsform

Artikel
(280)
Buchkapitel
(1)

Sprache

Englisch
(268)
Deutsch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(137)
Humans
(136)
Life Sciences & Biomedicine
(136)
Female
(110)
Oncology
(97)
Middle Aged
(72)
Biological And Medical Sciences
(58)
Breast Neoplasms - Drug Therapy
(54)
Medical Sciences
(54)
Aged
(51)
Adult
(50)
Breast Cancer
(46)
Breast Neoplasms - Pathology
(38)
Tumors
(38)
Chemotherapy
(28)
Gynecology. Andrology. Obstetrics
(28)
Mammary Gland Diseases
(28)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(25)
Chemotherapy, Adjuvant
(25)
Male
(25)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized controlled trial of the Valencia model of waking hypnosis plus CBT for pain, fatigue, and sleep management in patients with cancer and cancer survivors

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer

Abstract ES5-3: Late recurrence in ER-positive breast cancer

Optimising the dose of capecitabine in metastatic breast cancer: confused, clarified or confirmed?

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100

Promoting quality and evidence-based care in early-stage breast cancer follow-up

Characterisation of the HLA-DRB107:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes

EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial

High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer

Granulocyte-macrophage colony-stimulating factor : An effective adjuvant for protein and peptide-based vaccines

Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Summary of the National Cancer Institute (NCI) State of the Science Conference on preoperative therapy in invasive breast cancer

Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer

Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]‐sestamibi scintimammography

Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

PCN153 A Trial for Evaluating Breast Cancer Tumor Marker Use Impact: A Value of Research Analysis

[18F]Fluoroestradiol Radiation Dosimetry in Human PET Studies

Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood

Managing Metastatic Bone Pain: The Role of Bisphosphonates

American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004

5025 POSTER DISCUSSION Phase 3 Study of Iniparib (I) Plus Gemcitabine (G) and Carboplatin (C) in Metastatic Triple-negative Breast Cancer (mTNBC) – Results of an Exploratory Analysis by Prior Therapy

Suchergebnisse filtern